{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:15:14Z","timestamp":1787022914179,"version":"build-2736575974"},"reference-count":24,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND AND OBJECTIVES<\/jats:title>\n                    <jats:p>Despite advances in the prevention of rhesus (Rh)(D) alloimmunization, alloantibodies to Rh(D) and non-Rh(D) red blood cell antigens continue to be detected in \u223c4% of US pregnancies and can result in hemolytic disease of the fetus and newborn (HDFN). Recent reports on HDFN lack granularity and are unable to provide antibody-specific outcomes. The objective of this study was to calculate the frequency of alloimmunization in our large hospital system and summarize the outcomes based on antibody specificity, titer, and other clinical factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We identified all births in a 6-year period after a positive red blood cell antibody screen result during pregnancy and summarized their characteristics and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 707 neonates were born after a positive maternal antibody screen result (3.0\/1000 live births). In 31 (4%), the positive screen result was due to rhesus immune globulin alone. Of the 676 neonates exposed to alloantibodies, the direct antibody test (DAT) result was positive, showing antigen-positivity and evidence of HDFN in 37% of those tested. Neonatal disease was most severe with DAT-positive anti-Rh antibodies (c, C, D, e, E). All neonatal red blood cell transfusions (15) and exchange transfusions (6) were due to anti-Rh alloimmunization. No neonates born to mothers with anti-M, anti-S, anti-Duffy, anti-Kidd A, or anti-Lewis required NICU admission for hyperbilirubinemia or transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Alloimmunization to Rh-group antibodies continues to cause a majority of the severe HDFN cases in our hospital system. In neonates born to alloimmunized mothers, a positive DAT result revealing antigen-positivity is the best predictor of anemia and hyperbilirubinemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2023-064604","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T04:06:43Z","timestamp":1716523603000},"source":"Crossref","is-referenced-by-count":15,"title":["Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization"],"prefix":"10.1542","volume":"153","author":[{"given":"Timothy M.","family":"Bahr","sequence":"first","affiliation":[{"name":"aObstetric and Neonatal Operations"},{"name":"bDivision of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Tweddell","sequence":"additional","affiliation":[{"name":"bDivision of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Zalla","sequence":"additional","affiliation":[{"name":"aObstetric and Neonatal Operations"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Dizon-Townson","sequence":"additional","affiliation":[{"name":"cMaternal-Fetal Medicine, Intermountain Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin K.","family":"Ohls","sequence":"additional","affiliation":[{"name":"bDivision of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Henry","sequence":"additional","affiliation":[{"name":"aObstetric and Neonatal Operations"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Ilstrup","sequence":"additional","affiliation":[{"name":"dIntermountain Health Transfusion Services and Department of Pathology, Intermountain Medical Center, Murray, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"Kelley","sequence":"additional","affiliation":[{"name":"eAmerican National Red Cross, Salt Lake City, Utah"},{"name":"fDepartment of Pathology, University of Arizona College of Medicine, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Con Yee","family":"Ling","sequence":"additional","affiliation":[{"name":"aObstetric and Neonatal Operations"},{"name":"bDivision of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Lindgren","sequence":"additional","affiliation":[{"name":"aObstetric and Neonatal Operations"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"aObstetric and Neonatal Operations"},{"name":"bDivision of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Christensen","sequence":"additional","affiliation":[{"name":"aObstetric and Neonatal Operations"},{"name":"bDivision of Neonatology, Department of Pediatrics, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"issue":"1","key":"2024060102544914600_B1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3181\/00379727-43-11151","article-title":"An agglutinable factor in human blood recognized by immune sera for rhesus blood","volume":"43","author":"Landsteiner","year":"1940","journal-title":"Exp Biol Med"},{"issue":"3712","key":"2024060102544914600_B2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.151.3712.828","article-title":"Rh factor: prevention of isoimmunization and clinical trial on mothers","volume":"151","author":"Freda","year":"1966","journal-title":"Science"},{"issue":"19","key":"2024060102544914600_B3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM197505082921906","article-title":"Prevention of Rh hemolytic disease--ten years\u2019 clinical experience with Rh immune globulin","volume":"292","author":"Freda","year":"1975","journal-title":"N Engl J Med"},{"issue":"3","key":"2024060102544914600_B4","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/AOG.0000000000002528","article-title":"ACOG practice bulletin no. 192: management of alloimmunization during pregnancy","volume":"131","author":"ACOG Practice Bulletin No","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2024060102544914600_B5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3476(32)80057-0","article-title":"Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum and anemia of the newborn","volume":"1","author":"Diamond","year":"1932","journal-title":"J Pediatr"},{"issue":"2","key":"2024060102544914600_B6","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.xagr.2023.100203","article-title":"Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010","volume":"3","author":"Yu","year":"2023","journal-title":"AJOG Glob Rep"},{"issue":"6","key":"2024060102544914600_B7","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/trf.16350","article-title":"Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus","volume":"61","author":"Li","year":"2021","journal-title":"Transfusion"},{"issue":"4","key":"2024060102544914600_B8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.21307\/immunohematology-2019-021","article-title":"Anti-vel alloimmunization and severe hemolytic disease of the fetus and newborn","volume":"33","author":"Moise","year":"2019","journal-title":"Immunohematology"},{"issue":"25","key":"2024060102544914600_B9","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1080\/14767058.2022.2122041","article-title":"Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review","volume":"35","author":"Blyth","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"11","key":"2024060102544914600_B10","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/trf.15987","article-title":"Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: a retrospective study","volume":"60","author":"Rahimi-Levene","year":"2020","journal-title":"Transfusion"},{"issue":"4","key":"2024060102544914600_B11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1423-0410.1999.7740223.x","article-title":"The direct antiglobulin test: still a place for the tube technique?","volume":"77","author":"Tissot","year":"1999","journal-title":"Vox Sang"},{"issue":"2","key":"2024060102544914600_B12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"12","key":"2024060102544914600_B13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41372-023-01730-4","article-title":"A \u201cgold standard\u201d test for diagnosing and quantifying hemolysis in neonates and infants","volume":"43","author":"Christensen","year":"2023","journal-title":"J Perinatol"},{"issue":"12","key":"2024060102544914600_B14","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","article-title":"Thirty-five years of Rh prophylaxis","volume":"43","author":"Bowman","year":"2003","journal-title":"Transfusion"},{"key":"2024060102544914600_B15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"Delaney","year":"2015","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"3","key":"2024060102544914600_B16","doi-asserted-by":"crossref","first-page":"e2022058859","DOI":"10.1542\/peds.2022-058859","article-title":"Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"150","author":"Kemper","year":"2022","journal-title":"Pediatrics"},{"issue":"10","key":"2024060102544914600_B17","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41372-020-0652-y","article-title":"Comparison of end-tidal carbon monoxide measurements with direct antiglobulin tests in the management of neonatal hyperbilirubinemia","volume":"40","author":"Elsaie","year":"2020","journal-title":"J Perinatol"},{"issue":"6","key":"2024060102544914600_B18","first-page":"623","article-title":"Rh isoimmunization during pregnancy: antenatal prophylaxis","volume":"118","author":"Bowman","year":"1978","journal-title":"Can Med Assoc J"},{"issue":"8344","key":"2024060102544914600_B19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(83)90232-5","article-title":"The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae","volume":"2","author":"Tovey","year":"1983","journal-title":"Lancet"},{"issue":"1","key":"2024060102544914600_B20","first-page":"50","article-title":"McMaster conference on prevention of Rh immunization. 28\u201330 September, 1977","volume":"36","year":"1979","journal-title":"Vox Sang"},{"issue":"1","key":"2024060102544914600_B21","doi-asserted-by":"crossref","first-page":"F60","DOI":"10.1136\/fn.84.1.F60","article-title":"Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis","volume":"84","author":"Maayan-Metzger","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"11","key":"2024060102544914600_B22","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1111\/trf.12698","article-title":"Clinically significant hemolytic disease of the newborn secondary to passive transfer of anti-D from maternal RhIG","volume":"54","author":"Cohen","year":"2014","journal-title":"Transfusion"},{"issue":"2","key":"2024060102544914600_B23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bjhh.2016.01.006","article-title":"Is antenatal RhIg completely safe?","volume":"38","author":"Subramaniyan","year":"2016","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"11","key":"2024060102544914600_B24","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/trf.12858","article-title":"Need to clarify the cause of hemolysis in case report of newborn with clinically significant hemolytic disease and passive transfer of anti-D from maternal RhIG","volume":"54","author":"Watchko","year":"2014","journal-title":"Transfusion"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-064604\/1659167\/peds.2023-064604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-064604\/1659167\/peds.2023-064604.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T22:55:54Z","timestamp":1717196154000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/153\/6\/e2023064604\/197355\/Neonatal-and-Obstetrical-Outcomes-of-Pregnancies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,5,24]]},"published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2023-064604","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"article-number":"e2023064604"}}